Logo image of ABO.DE

CLEARVISE AG (ABO.DE) Stock Fundamental Analysis

FRA:ABO - Deutsche Boerse Ag - DE000A1EWXA4 - Common Stock - Currency: EUR

1.7  -0.03 (-1.73%)

Fundamental Rating

4

Overall ABO gets a fundamental rating of 4 out of 10. We evaluated ABO against 21 industry peers in the Independent Power and Renewable Electricity Producers industry. ABO has an excellent profitability rating, but there are concerns on its financial health. ABO does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

ABO had positive earnings in the past year.
In multiple years ABO reported negative net income over the last 5 years.
In the past 5 years ABO always reported a positive cash flow from operatings.
ABO.DE Yearly Net Income VS EBIT VS OCF VS FCFABO.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M 20M 30M 40M

1.2 Ratios

ABO's Return On Assets of 2.23% is fine compared to the rest of the industry. ABO outperforms 71.43% of its industry peers.
With a decent Return On Equity value of 5.28%, ABO is doing good in the industry, outperforming 71.43% of the companies in the same industry.
ABO has a Return On Invested Capital of 5.26%. This is amongst the best in the industry. ABO outperforms 80.95% of its industry peers.
ABO had an Average Return On Invested Capital over the past 3 years of 3.36%. This is below the industry average of 6.07%.
The 3 year average ROIC (3.36%) for ABO is below the current ROIC(5.26%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.23%
ROE 5.28%
ROIC 5.26%
ROA(3y)1.73%
ROA(5y)1.25%
ROE(3y)4.2%
ROE(5y)3.42%
ROIC(3y)3.36%
ROIC(5y)3.36%
ABO.DE Yearly ROA, ROE, ROICABO.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5 10

1.3 Margins

With a decent Profit Margin value of 11.75%, ABO is doing good in the industry, outperforming 61.90% of the companies in the same industry.
In the last couple of years the Profit Margin of ABO has grown nicely.
Looking at the Operating Margin, with a value of 30.43%, ABO is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
ABO's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 95.24%, ABO belongs to the top of the industry, outperforming 95.24% of the companies in the same industry.
ABO's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 30.43%
PM (TTM) 11.75%
GM 95.24%
OM growth 3Y-2.84%
OM growth 5Y2.37%
PM growth 3Y32.86%
PM growth 5YN/A
GM growth 3Y-1.68%
GM growth 5Y-0.98%
ABO.DE Yearly Profit, Operating, Gross MarginsABO.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40 60 80

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ABO is creating some value.
Compared to 1 year ago, ABO has about the same amount of shares outstanding.
ABO has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ABO has an improved debt to assets ratio.
ABO.DE Yearly Shares OutstandingABO.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M
ABO.DE Yearly Total Debt VS Total AssetsABO.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

2.2 Solvency

ABO has an Altman-Z score of 0.91. This is a bad value and indicates that ABO is not financially healthy and even has some risk of bankruptcy.
ABO's Altman-Z score of 0.91 is fine compared to the rest of the industry. ABO outperforms 61.90% of its industry peers.
A Debt/Equity ratio of 1.00 is on the high side and indicates that ABO has dependencies on debt financing.
ABO's Debt to Equity ratio of 1.00 is in line compared to the rest of the industry. ABO outperforms 52.38% of its industry peers.
Industry RankSector Rank
Debt/Equity 1
Debt/FCF N/A
Altman-Z 0.91
ROIC/WACC1.2
WACC4.38%
ABO.DE Yearly LT Debt VS Equity VS FCFABO.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M

2.3 Liquidity

ABO has a Current Ratio of 1.17. This is a normal value and indicates that ABO is financially healthy and should not expect problems in meeting its short term obligations.
ABO has a Current ratio (1.17) which is comparable to the rest of the industry.
A Quick Ratio of 1.17 indicates that ABO should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.17, ABO perfoms like the industry average, outperforming 52.38% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.17
Quick Ratio 1.17
ABO.DE Yearly Current Assets VS Current LiabilitesABO.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M

3

3. Growth

3.1 Past

The earnings per share for ABO have decreased strongly by -73.01% in the last year.
ABO shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 21.96% yearly.
The Revenue for ABO has decreased by -31.18% in the past year. This is quite bad
ABO shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.20% yearly.
EPS 1Y (TTM)-73.01%
EPS 3Y21.96%
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-31.18%
Revenue growth 3Y7.15%
Revenue growth 5Y7.2%
Sales Q2Q%N/A

3.2 Future

ABO is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -31.24% yearly.
The Revenue is expected to grow by 3.58% on average over the next years.
EPS Next Y-138.86%
EPS Next 2Y-52.9%
EPS Next 3Y-32.16%
EPS Next 5Y-31.24%
Revenue Next Year-17.04%
Revenue Next 2Y-2.32%
Revenue Next 3Y3.58%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ABO.DE Yearly Revenue VS EstimatesABO.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M
ABO.DE Yearly EPS VS EstimatesABO.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2020 2021 2022 2023 2024 2025 2026 2027 0 0.05 -0.05 0.1 0.15

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 15.45, which indicates a correct valuation of ABO.
ABO's Price/Earnings ratio is in line with the industry average.
The average S&P500 Price/Earnings ratio is at 28.79. ABO is valued slightly cheaper when compared to this.
ABO is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 15.45
Fwd PE N/A
ABO.DE Price Earnings VS Forward Price EarningsABO.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ABO is valued a bit cheaper than the industry average as 71.43% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.14
ABO.DE Per share dataABO.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

The decent profitability rating of ABO may justify a higher PE ratio.
A cheap valuation may be justified as ABO's earnings are expected to decrease with -32.16% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-52.9%
EPS Next 3Y-32.16%

3

5. Dividend

5.1 Amount

ABO has a Yearly Dividend Yield of 3.57%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 4.10, ABO pays a bit more dividend than its industry peers.
ABO's Dividend Yield is a higher than the S&P500 average which is at 2.51.
Industry RankSector Rank
Dividend Yield 3.57%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

DP0%
EPS Next 2Y-52.9%
EPS Next 3Y-32.16%
ABO.DE Yearly Income VS Free CF VS DividendABO.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M 10M 15M 20M 25M

CLEARVISE AG

FRA:ABO (4/25/2025, 7:00:00 PM)

1.7

-0.03 (-1.73%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryIndependent Power and Renewable Electricity Producers
Earnings (Last)N/A N/A
Earnings (Next)04-28 2025-04-28/amc
Inst Owners5.76%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap128.11M
Analysts85
Price Target3.37 (98.24%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.57%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-13.87%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.27%
Valuation
Industry RankSector Rank
PE 15.45
Fwd PE N/A
P/S 1.77
P/FCF N/A
P/OCF N/A
P/B 0.8
P/tB 0.8
EV/EBITDA 7.14
EPS(TTM)0.11
EY6.47%
EPS(NY)-0.02
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.96
BVpS2.13
TBVpS2.13
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.23%
ROE 5.28%
ROCE 6.47%
ROIC 5.26%
ROICexc 5.89%
ROICexgc 5.89%
OM 30.43%
PM (TTM) 11.75%
GM 95.24%
FCFM N/A
ROA(3y)1.73%
ROA(5y)1.25%
ROE(3y)4.2%
ROE(5y)3.42%
ROIC(3y)3.36%
ROIC(5y)3.36%
ROICexc(3y)4.06%
ROICexc(5y)3.9%
ROICexgc(3y)4.12%
ROICexgc(5y)3.99%
ROCE(3y)4.14%
ROCE(5y)4.13%
ROICexcg growth 3Y-12.43%
ROICexcg growth 5Y0.76%
ROICexc growth 3Y-11.33%
ROICexc growth 5Y1.65%
OM growth 3Y-2.84%
OM growth 5Y2.37%
PM growth 3Y32.86%
PM growth 5YN/A
GM growth 3Y-1.68%
GM growth 5Y-0.98%
F-ScoreN/A
Asset Turnover0.19
Health
Industry RankSector Rank
Debt/Equity 1
Debt/FCF N/A
Debt/EBITDA 4.05
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.17
Quick Ratio 1.17
Altman-Z 0.91
F-ScoreN/A
WACC4.38%
ROIC/WACC1.2
Cap/Depr(3y)80.88%
Cap/Depr(5y)48.91%
Cap/Sales(3y)30.59%
Cap/Sales(5y)18.56%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-73.01%
EPS 3Y21.96%
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y-138.86%
EPS Next 2Y-52.9%
EPS Next 3Y-32.16%
EPS Next 5Y-31.24%
Revenue 1Y (TTM)-31.18%
Revenue growth 3Y7.15%
Revenue growth 5Y7.2%
Sales Q2Q%N/A
Revenue Next Year-17.04%
Revenue Next 2Y-2.32%
Revenue Next 3Y3.58%
Revenue Next 5YN/A
EBIT growth 1Y-65.91%
EBIT growth 3Y4.1%
EBIT growth 5Y9.75%
EBIT Next Year71.88%
EBIT Next 3Y31.87%
EBIT Next 5YN/A
FCF growth 1Y-26.38%
FCF growth 3Y-14.34%
FCF growth 5Y6.36%
OCF growth 1Y-66.66%
OCF growth 3Y-13.84%
OCF growth 5Y-5.59%